Consistency among different PSMA ligands for defining PSMA-overexpression prior to PSMA-targeted therapy in prostate cancer

被引：0
|
作者：
Heilinger, Jan [1 ,2 ]
Weindler, Jasmin [3 ]
Roth, Katrin [1 ,2 ]
Krapf, Philipp [4 ]
Neumaier, Bernd [5 ,6 ]
Schomaecker, Klaus
Dietlein, Markus
Drzezga, Alexander [7 ,8 ]
Kobe, Carsten
机构：
[1] Univ Cologne, Fac Med, Dept Nucl Med, Cologne, Germany
[2] Univ Cologne, Univ Hosp Cologne, Cologne, Germany
[3] Univ Cologne, Dept Nucl Med, Cologne, Germany
[4] INM 5, Julich, Germany
[5] Univ Cologne, Inst Radiochem & Expt Mol Imaging, Cologne, Germany
[6] Forschungszentrum Julich, Nucl Chem, Inst Neurosci & Med INM 5, Julich, Germany
[7] Univ Hosp Cologne, Dept Nucl Med, Cologne, Germany
[8] Inst Neurosci & Med INM 2, Mol Org Brain, Julich, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2024年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
241353
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer
    Hammer, Stefanie
    Hagemann, Urs B.
    Zitzmann-Kolbe, Sabine
    Larsen, Aasmund
    Ellingsen, Christine
    Geraudie, Solene
    Grant, Derek
    Indrevoll, Baard
    Smeets, Roger
    von Ahsen, Oliver
    Kristian, Alexander
    Lejeune, Pascale
    Hennekes, Hartwig
    Karlsson, Jenny
    Bjerke, Roger M.
    Ryan, Olav B.
    Cuthbertson, Alan S.
    Mumberg, Dominik
    CLINICAL CANCER RESEARCH, 2020, 26 (08) : 1985 - 1996
  • [22] Investigating PSMA-Targeted Radioligand Therapy Efficacy as a Function of Cellular PSMA Levels and Intratumoral PSMA Heterogeneity
    Current, Kyle
    Meyer, Catherine
    Magyar, Clara E.
    Mona, Christine E.
    Almajano, Joel
    Slavik, Roger
    Stuparu, Andreea D.
    Cheng, Chloe
    Dawson, David W.
    Radu, Caius G.
    Czernin, Johannes
    Lueckerath, Katharina
    CLINICAL CANCER RESEARCH, 2020, 26 (12) : 2946 - 2955
  • [23] PSMA-targeted radioligand therapy in prostate cancer: current status and future prospects
    Parghane, Rahul, V
    Basu, Sandip
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (09) : 959 - 975
  • [24] PSMA-targeted photodynamic therapy in surgical prostate tumor samples
    Derks, Y.
    Schilham, M.
    van Lith, S.
    Sedelaar, M.
    Somford, D.
    Gotthardt, M.
    Lowik, D.
    Lutje, S.
    Heskamp, S.
    Rijpkema, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S315 - S315
  • [25] Antiandrogen modulation of prostate-specific membrane antigen (PSMA): Dynamics and synergy with PSMA-targeted therapy
    Murga, Jose D.
    Magargal, Wells W.
    Moorji, Sameer M.
    DiPippo, Vincent A.
    Olson, William C.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [26] Value proposition of PSMA-targeted α–particle radioligand therapy in metastatic prostate cancer
    Hossein Jadvar
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 8 - 10
  • [27] PSMA-targeted imaging of prostate cancer: the best is yet to come
    Gorin, Michael A.
    Pomper, Martin G.
    Rowe, Steven P.
    BJU INTERNATIONAL, 2016, 117 (05) : 715 - 716
  • [28] PSMA-targeted imaging of prostate cancer: evolution of a success story
    Maurer, Tobias
    Eiber, Matthias
    ASIAN JOURNAL OF ANDROLOGY, 2017, 19 (03) : 388 - 388
  • [29] Precision strikes: PSMA-targeted radionuclide therapy in prostate cancer - a narrative review
    Szponar, Pawel
    Petrasz, Piotr
    Brzezniakiewicz-Janus, Katarzyna
    Drewa, Tomasz
    Zorga, Piotr
    Adamowicz, Jan
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [30] PSMA-targeted contrast agents for intraoperative imaging of prostate cancer
    Bao, Kai
    Lee, Jeong Heon
    Kang, Homan
    Park, G. Kate
    El Fakhri, Georges
    Choi, Hak Soo
    CHEMICAL COMMUNICATIONS, 2017, 53 (10) : 1611 - 1614
12345